Paper36915146
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
Ibarra-Estrada M and 11 others. Crit Care, 2023. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Papers, record 36915146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915146
- Disease
- Sepsis231 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Shock, Septic | Major topic |
| Sepsis | Major topic |
| Humans | |
| Methylene Blue | |
| Vasoconstrictor Agents |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04446871 | Methylene Blue in Early Septic Shock | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT06306001 | Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock | Results | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 37644588 | Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy. | https://conductscience.org/library/papers/37644588 | PubMed |
| Comment in | 37670332 | Drug diluent and efficacy of methylene blue in septic shock: authors' reply. | https://conductscience.org/library/papers/37670332 | PubMed |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26125087 | NOREPINEPHRINE: NOT TOO MUCH, TOO LONG. | Shock | 2015 | https://conductscience.org/library/papers/26125087 | PubMed |
| 2 | 12500513 | The influence of methylene blue infusion on cytokine levels during severe sepsis. | Anaesth Intensive Care | 2002 | https://conductscience.org/library/papers/12500513 | PubMed |
| 3 | 31520103 | Less is more: catecholamine-sparing strategies in septic shock. | Intensive Care Med | 2019 | https://conductscience.org/library/papers/31520103 | PubMed |
| 4 | 14707556 | Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. | Crit Care Med | 2004 | https://conductscience.org/library/papers/14707556 | PubMed |
| 5 | 32520577 | Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis. | Am J Respir Crit Care Med | 2020 | https://conductscience.org/library/papers/32520577 | PubMed |
| 6 | 34582425 | Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. | Crit Care Med | 2022 | https://conductscience.org/library/papers/34582425 | PubMed |
| 7 | 20109575 | A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. | Nitric Oxide | 2010 | https://conductscience.org/library/papers/20109575 | PubMed |
| 8 | 8750129 | Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. | Intensive Care Med | 1995 | https://conductscience.org/library/papers/8750129 | PubMed |
| 9 | 26903338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 10 | 35311781 | Early Multimodal Vasopressors-Are We Ready for It? | Crit Care Med | 2022 | https://conductscience.org/library/papers/35311781 | PubMed |
| 11 | 36398968 | Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis. | Crit Care Med | 2023 | https://conductscience.org/library/papers/36398968 | PubMed |
| 12 | 24078299 | Methylene blue does not have to be considered only as rescue therapy for distributive shock. | J Med Toxicol | 2013 | https://conductscience.org/library/papers/24078299 | PubMed |
| 13 | 29347874 | Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29347874 | PubMed |
| 14 | 26683506 | Pharmacodynamic Analysis of a Fluid Challenge. | Crit Care Med | 2016 | https://conductscience.org/library/papers/26683506 | PubMed |
| 15 | 32019600 | Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. | Crit Care | 2020 | https://conductscience.org/library/papers/32019600 | PubMed |
| 16 | 26123610 | Respiratory variation in carotid peak systolic velocity predicts volume responsiveness in mechanically ventilated patients with septic shock: a prospective cohort study. | Crit Ultrasound J | 2015 | https://conductscience.org/library/papers/26123610 | PubMed |
| 17 | 30410284 | Angiotensin II Brings More Questions Than Answers. | P T | 2018 | https://conductscience.org/library/papers/30410284 | PubMed |
| 18 | 32705530 | Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review. | Adv Ther | 2020 | https://conductscience.org/library/papers/32705530 | PubMed |
| 19 | 32270211 | Noradrenaline drives immunosuppression in sepsis: clinical consequences. | Intensive Care Med | 2020 | https://conductscience.org/library/papers/32270211 | PubMed |
| 20 | 9869542 | Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. | J Crit Care | 1998 | https://conductscience.org/library/papers/9869542 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978844 | The potential role of methylene blue as an adjunctive therapy in septic shock. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42978844 | PubMed |
| 42827248 | Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies. | Crit Care | 2026 | https://conductscience.org/library/papers/42827248 | PubMed |
| 42719392 | Lung-Cardiovascular Interactions and Derangements in ARDS. | Compr Physiol | 2026 | https://conductscience.org/library/papers/42719392 | PubMed |
| 42565679 | Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX. | Proc (Bayl Univ Med Cent) | 2026 | https://conductscience.org/library/papers/42565679 | PubMed |
| 42355649 | The Effectiveness of Methylene Blue in Adult Shock: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355649 | PubMed |
| 42277950 | Current and future strategies aiming at reducing catecholamine exposure in septic shock. | Crit Care | 2026 | https://conductscience.org/library/papers/42277950 | PubMed |
| 42110642 | Machine learning for prediction of in-ICU mortality in sepsis: an observational study using the MIMIC IV database. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42110642 | PubMed |
| 42090639 | Effect of Weight-based versus Absolute Norepinephrine Dosing on Mortality Risk in Obese Patients with Septic Shock: An Observational, Multicohort, Retrospective Study. | Anesthesiology | 2026 | https://conductscience.org/library/papers/42090639 | PubMed |
| 42088182 | Methylene blue: An adjunct therapy in shock patients in resource-poor settings. | J Anaesthesiol Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42088182 | PubMed |
| 41959519 | Deciphering sepsis molecular subtypes using large-scale data to identify subtype-specific drug repurposing. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959519 | PubMed |
| 41870560 | Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. | Intensive Care Med | 2026 | https://conductscience.org/library/papers/41870560 | PubMed |
| 41805397 | A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock. | Perfusion | 2026 | https://conductscience.org/library/papers/41805397 | PubMed |
| 41731020 | A multimodal embedding model for sepsis data representation. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/41731020 | PubMed |
| 41580807 | Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trial. | Scand J Trauma Resusc Emerg Med | 2026 | https://conductscience.org/library/papers/41580807 | PubMed |
| 41477182 | The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41477182 | PubMed |
| 41388310 | Management of post-resuscitation vasoplegic shock: targets, strategies and outcomes. | Crit Care | 2025 | https://conductscience.org/library/papers/41388310 | PubMed |
| 41377532 | Current and emerging therapeutic options for refractory septic shock: A systematic review. | World J Crit Care Med | 2025 | https://conductscience.org/library/papers/41377532 | PubMed |
| 41210023 | Use of Methylene Blue in Patients With Shock in the Intensive Care Unit Over a 10-Year Period at a Private Hospital in Costa Rica. | Cureus | 2025 | https://conductscience.org/library/papers/41210023 | PubMed |
| 41206424 | Use of Methylene Blue to Treat Hypotension in Poisoned Patients in the Toxicology Investigators Consortium (ToxIC) Core Registry: 2016-2023. | J Med Toxicol | 2026 | https://conductscience.org/library/papers/41206424 | PubMed |
| 41141023 | Methylene Blue for Refractory Shock Due to Acute Pancreatitis and Cholangitis. | Cureus | 2025 | https://conductscience.org/library/papers/41141023 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CHKA | 1119 | PubTator's text mining | https://conductscience.org/library/genes/1119 | NCBI Gene |
| GGH | 8836 | PubTator's text mining | https://conductscience.org/library/genes/8836 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| HBG2 | 3048 | PubTator's text mining | https://conductscience.org/library/genes/3048 | NCBI Gene |
| NOS2 | 4843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| METHYLENE BLUE | CHEMBL550495 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL550495 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36915146
GET https://conductscience.org/api/papers/v1/36915146/references?page=2